“The Role of CD-19 Targeting Chimeric Antigen Receptor (CAR) T-cell Therapy in Non-Hodgkin Lymphoma”, HYMR, vol. 2, no. 2, Dec. 2024, doi: 10.59707/hymrFHJX7726.